Back to search
FDAFDA · Food and drugs·Recall number D-0114-2021

Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

Published December 9, 2020 · Recall initiated: November 18, 2020

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification for dissolution.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
The Harvard Drug Group
Distributor
Nationwide
Lot
Lots: T02520, T02637, exp 02/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card